{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:59:41Z","timestamp":1791176381266,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.prp.2014.01.011","type":"journal-article","created":{"date-parts":[[2014,2,12]],"date-time":"2014-02-12T18:17:17Z","timestamp":1392229037000},"page":"307-311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["KRAS mutational analysis in ductal adenocarcinoma of the pancreas and its clinical significance"],"prefix":"10.1016","volume":"210","author":[{"given":"Umberto","family":"Miglio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Oldani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Mezzapelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Veggiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Paganotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Garavoglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Boldorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2014.01.011_bib0005","first-page":"241","article-title":"Epidemiology and risk factors in pancreatic cancer","volume":"23","author":"Ahlgren","year":"1996","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.prp.2014.01.011_bib0010","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1158\/0008-5472.CAN-06-4158","article-title":"Oncogenic activation of the RAS\/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies","volume":"67","author":"Benvenuti","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2014.01.011_bib0015","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1053\/j.gastro.2013.01.071","article-title":"Roles for KRAS in pancreatic tumor development and progression","volume":"144","author":"Di Magliano","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prp.2014.01.011_bib0020","first-page":"294","article-title":"The utility of Ki-ras mutation analysis in the cytologic diagnosis of the pancreatobiliary neoplasma","volume":"6","author":"Dillon","year":"2000","journal-title":"Cancer J."},{"key":"10.1016\/j.prp.2014.01.011_bib0025","first-page":"9367","article-title":"K-ras topographic genotyping of pancreatic adenocarcinoma","volume":"12","author":"Finkelstein","year":"1994","journal-title":"Arch. Surg."},{"key":"10.1016\/j.prp.2014.01.011_bib0030","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/(SICI)1097-0142(19960901)78:5<986::AID-CNCR7>3.0.CO;2-A","article-title":"Clinicpathologic features of small pancreatic adenocarcinoma. A collective study","volume":"78","author":"Furukawa","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2014.01.011_bib0035","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/bjs.4484","article-title":"Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma","volume":"91","author":"Wagner","year":"2004","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.prp.2014.01.011_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0960-7404(97)00001-7","article-title":"The molecular genetics of pancreatic cancer","volume":"6","author":"Howe","year":"1997","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.prp.2014.01.011_bib0045","series-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System","first-page":"279","article-title":"Ductal adenocarcinoma of the pancreas","author":"Hruban","year":"2010"},{"key":"10.1016\/j.prp.2014.01.011_bib0050","first-page":"2969","article-title":"Progression model for pancreatic cancer","volume":"6","author":"Hruban","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2014.01.011_bib0055","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1158\/1078-0432.CCR-11-3210","article-title":"Specific mutations in KRAS codons 12 and 13, and patient prognosis in 1075 BRAF wild-type colorectal cancers","volume":"18","author":"Imamura","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2014.01.011_bib0060","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s00428-006-0191-8","article-title":"Molecular analysis of the EGFR-RAS-RAF pathway in pancreatic ductal adenocarcinomas: lack of mutations in the BRAF and EGFR genes","volume":"448","author":"Immervoll","year":"2006","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2014.01.011_bib0065","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/1097-0215(20001120)89:6<469::AID-IJC1>3.0.CO;2-L","article-title":"K-RAS oncogene subtype mutations are associated with survival but not expression of p53, p16INK4A, p21WAF-1, cyclin D1, ERBB-2 and ERBB-3 in resected pancreatic ductal adenocarcinoma","volume":"89","author":"Kawesha","year":"2000","journal-title":"Int. J. Cancer (Pred. Oncol.)"},{"key":"10.1016\/j.prp.2014.01.011_bib0070","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1136\/gut.2005.083063","article-title":"Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins","volume":"55","author":"Kim","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.prp.2014.01.011_bib0075","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/bjc.2011.26","article-title":"KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients","volume":"104","author":"Knijn","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2014.01.011_bib0080","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/cncr.22559","article-title":"Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplifications, and KRAS mutations on survival of pancreatic adenocarcinoma","volume":"109","author":"Lee","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2014.01.011_bib0085","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/bjc.2013.130","article-title":"Mutation analysis of the EGFR gene and downstream signalling pathway in histologic samples of malignant pleural mesothelioma","volume":"108","author":"Mezzapelle","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2014.01.011_bib0090","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/MPA.0b013e3182327a03","article-title":"EGFR and KRAS mutational analysis and their correlation to survival in pancreatic and periampullary cancer","volume":"41","author":"Oliveira-Cunha","year":"2012","journal-title":"Pancreas"},{"key":"10.1016\/j.prp.2014.01.011_bib0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ijc.2910570206","article-title":"Pancreatic cancer in Europe: Ki-ras gene mutation pattern shows geographical differences","volume":"57","author":"Scarpa","year":"1994","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2014.01.011_bib0100","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/MPA.0b013e31823cd9df","article-title":"Frequency and prognostic role of KRAS and BRAF mutations in patients with localized pancreatic and ampullary adenocarcinomas","volume":"41","author":"Schultz","year":"2012","journal-title":"Pancreas"},{"key":"10.1016\/j.prp.2014.01.011_bib0105","first-page":"1223","article-title":"K-ras and p53 in pancreatic cancer: association with medical history, histopathology, and environmental exposures in a population-based study","volume":"9","author":"Slebos","year":"2000","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.prp.2014.01.011_bib0110","doi-asserted-by":"crossref","first-page":"7773","DOI":"10.1093\/nar\/16.16.7773","article-title":"KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas","volume":"16","author":"Smit","year":"1988","journal-title":"Nucleic Acid Res."},{"key":"10.1016\/j.prp.2014.01.011_bib0115","first-page":"5171","article-title":"KRAS mutation testing in metastatic colorectal cancer","volume":"18","author":"Tan","year":"2012","journal-title":"World J. Gastroenterol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033814000399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033814000399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T12:52:29Z","timestamp":1648299149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033814000399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0344033814000399"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2014.01.011","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KRAS mutational analysis in ductal adenocarcinoma of the pancreas and its clinical significance","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2014.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}